Skip to main content
. 2016 Nov 21;60(12):7321–7332. doi: 10.1128/AAC.01588-16

FIG 2.

FIG 2

Mean methemoglobin levels as a percentage of hemoglobin (± standard deviations) (A) and mean hemoglobin levels (± standard deviations) (B) following dosing with tafenoquine (TQ), artemether-lumefantrine (AL), dihydroartemisinin-piperaquine (DHA-PQP), artemether-lumefantrine plus tafenoquine, or dihydroartemisinin-piperaquine plus tafenoquine.